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Experience over several years has indicated that chemotherapy, even if widely
used, does not always remain effective in the therapy of lung tumours and, in
addition, is linked to serious side effects. In parallel, some plant polyphenols are
known to exert a proapoptotic action on tumour cells while, in contrast, repre-
senting anti-cancerogenic anti-oxidants in living organisms. Our studies were
aimed at comparing the effects of a polyphenol, quercetin, and cisplatin on cells
of various types of lung cancer in in vitro conditions. In these studies we also
attempted to define the relationship between the dose and the duration of the
activity of the compounds. Cisplatin alone was found to induce only a small
reaction in the cells, while in combination with quercetin its anti-proliferative
and pro-apoptotic effects were amplified, depending upon the type of tumour,
the dose and the duration of the drug’s action.
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INTRODUCTION
Cisplatin or cis-diaminedichloroplatinum (DDP)
represents a widely used drug in several types of
tumour, including those of the lungs. Regrettably, it
is not always effective and its application is linked to
serious side affects. First of all, the drug is both neph-
rotoxic and ototoxic and damages the bone marrow
[6]. Plant polyphenols, including quercetin, are de-
scribed as agents of anti-cancerogenic properties due
to their anti-proliferative and pro-apoptotic activity
on tumour cells and represent very strong anti-oxi-
dants [7]. This suggests a potential for a combined
chemotherapy with polyphenol supplementation,
which might amplify the chemotherapeutic effects
but which might be accompanied by fewer side ef-
fects. The preliminary in vivo and in vitro studies seem
to confirm these expectations [1, 2, 5]. Since cispl-
atin is frequently used to treat lung tumours, our
experiments have been performed on cell cultures
involving two cell lines of lung cancer.
MATERIAL AND METHODS
The studies were performed in vitro on two cell
lines: SW1271 (small cell lung cancer, SCLC) and A549
(pulmonary adenocarcinoma). The cultures were
established in 25 cm2 flasks and maintained at 37oC
in 5% CO2. MEM medium was used, supplemented
with foetal calf serum and antibiotics (Biokom). The
cells were harvested using trypsin and subcultured
in 24-well plates at 2 ¥ 104 per ml MEM. After 24 h
culture the cells were scored in a Bürker haemocy-
tometer and the cultures supplemented with quer-
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cetin (Sigma) and/or cisplatin in appropriate concen-
trations and in 5 combinations: 1) 5 µM quercetin;
2) 10 µM quercetin; 3) 500 ng/ml (1.6 ¥ 10-3 µM) DDP
[3]; 4) 5 µM quercetin plus 500 ng/ml DDP; 5) 10 µM
quercetin plus 500 ng/ml DDP. Some wells of the
plate were left unsupplemented, serving as a con-
trol. In the cultures the cells were scored following
24, 48 and 72 h. The percentage of apoptotic cells,
necrotic cells and cells with intermediate lesions was
tested using the comet technique [4].
RESULTS AND DISCUSSION
The results of our studies indicated that querce-
tin reduced cell number in the cell culture both in
the case of A549 and that of SW1271 and that the
process depended upon the dose of drugs and the
duration of incubation (Fig. 1). The most pronounced
effect was noted in the case of SW1271 following
48 h incubation and in the case of A549 following
72 h incubation. The reaction of cells to DDP was
relatively mild in the cell lines studied and was most
pronounced in A549 following 72 h exposure to the
drug. SW1271 cells were less sensitive to DDP, par-
ticularly following longer incubations, which suggest-
ed the potential for development of cell clones re-
sistant to the cytostatic drug. The application of both
drugs, quercetin and DDP, in parallel was followed
by a clearly amplified anti-proliferative effect, par-
ticularly in the case of SW1271 after 24 h (Fig. 1B).
The effects were not related to the concentration of
quercetin. In the case of A549 the reaction devel-
oped after a longer incubation time and was dose-
dependent (Fig. 2A). Moreover, the studies demon-
strated that DDP alone was very inefficient in the
induction of apoptosis in the cell lines studied and,
after 48 h, the lesions were mainly of an intermedi-
ate type (Fig. 2). Quercetin administered without DDP
exerted a pro-apoptotic action, particularly in the
case of SCLC cells. On the other hand, the combina-
tion of quercetin and DDP applied to SW1271 cul-
tures augmented both the number of apoptotic cell
nuclei and the intermediate type comets, which
might also reflect the presence of apoptotic cells
(Fig. 2B). In A549 cells the amplified effect was ob-
served only after 48 h (Fig. 2A).
The studies performed suggest that quercetin
may amplify the action of cisplatin, particularly in
the case of SCLC, in which the drug is most frequently
used, although it seldom results in a complete re-
mission [6]. Studies performed in vitro have con-
firmed both a more pronounced reduction in cell
number and more evident apoptosis following the
addition of DDP in combination with quercetin. To
sum up, our results may prove suitable for augment-
ing the sensitivity of tumour cells to DDP in some
lung tumours, particularly in cases which are resis-
tant to cisplatin.
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Figure 1. Cell content in cultures in relation to type, concentration and duration of exposure to the drug. Abscissa: 1) 5 µM quercetin,
2) 10 µM quercetin, 3) DDP 500 ng/ml, 4) 5 µM quercetin + DDP 500 ng/ml, 5), 10 µM quercetin +DDP 500 ng/ml; A. A549 cell line,
B. SW1271 cell line; DDP, cisplatin — cis-diaminedichloroplatinum, SCLC — small cell lung cancer
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Figure 2. Percentage of apoptotic cell nuclei in relation to type, concentration and duration of exposure to the drug. Abscissa: 1) 5 µM
quercetin, 2) 10 µM quercetin, 3) DDP 500 ng/ml, 4) 5 µM quercetin + DDP 500 ng/ml, 5), 10 µM quercetin +DDP 500 ng/ml; A. A549
cell line, B. SW1271 cell line; DDP, cisplatin — cis-diaminedichloroplatinum, SCLC — small cell lung cancer
